These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 32100025

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
    Wang XD, Feng SJ, Liu JP, Song TR, Huang ZL, Fan Y, Shi YY, Chen LY, Lv YH, Xu ZL, Li XH, Wang L, Lin T.
    BMC Infect Dis; 2021 Jan 09; 21(1):41. PubMed ID: 33422017
    [Abstract] [Full Text] [Related]

  • 3. Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients.
    Yin S, Wu L, Zhang F, Huang X, Wu J, Wang X, Lin T.
    Liver Int; 2023 Nov 09; 43(11):2415-2424. PubMed ID: 37592870
    [Abstract] [Full Text] [Related]

  • 4. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E, Strasser SI, Koorey DJ, Verran D, McCaughan GW.
    Clin Transplant; 2006 Nov 09; 20(3):369-73. PubMed ID: 16824156
    [Abstract] [Full Text] [Related]

  • 5. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG.
    World J Gastroenterol; 2018 Dec 28; 24(48):5525-5536. PubMed ID: 30622380
    [Abstract] [Full Text] [Related]

  • 6. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors.
    Satterthwaite R, Ozgu I, Shidban H, Aswad S, Sunga V, Zapanta R, Asai P, Bogaard T, Khetan U, Mendez RG, Mendez R.
    Transplantation; 1997 Aug 15; 64(3):432-5. PubMed ID: 9275109
    [Abstract] [Full Text] [Related]

  • 7. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
    Holt D, Thomas R, Van Thiel D, Brems JJ.
    Arch Surg; 2002 May 15; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F.
    Transplantation; 1995 Jan 27; 59(2):230-4. PubMed ID: 7839446
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
    Wang Y, Shu M, Chen J, Shen F, Ren H, Yu Y.
    Front Public Health; 2023 Jan 27; 11():1302183. PubMed ID: 38179572
    [Abstract] [Full Text] [Related]

  • 12. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW, Lee DS, Lee HH, Kim SJ, Joh JW, Seo JM, Choe YH, Lee SK.
    Transplant Proc; 2004 Oct 27; 36(8):2311-2. PubMed ID: 15561233
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.
    Rao W, Xie M, Yang T, Zhang JJ, Gao W, Deng YL, Zheng H, Pan C, Liu YH, Shen ZY.
    World J Gastroenterol; 2014 Sep 28; 20(36):13159-66. PubMed ID: 25278711
    [Abstract] [Full Text] [Related]

  • 14. Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
    Bohorquez HE, Cohen AJ, Girgrah N, Bruce DS, Carmody IC, Joshi S, Reichman TW, Therapondos G, Mason AL, Loss GE.
    Liver Transpl; 2013 Jun 28; 19(6):611-8. PubMed ID: 23526668
    [Abstract] [Full Text] [Related]

  • 15. Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang A, Wu Y, Tan Y, Shi J, Zhao Y, Hu Y, Yu J, Zheng W, Lai X, Zhang M, Zhu Y, Ye Y, Huang Y, Fu S, Huang H, Luo Y.
    Biol Blood Marrow Transplant; 2020 May 28; 26(5):956-964. PubMed ID: 31962163
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
    Mahboobi N, Tabatabaei SV, Blum HE, Alavian SM.
    Transpl Infect Dis; 2012 Oct 28; 14(5):445-51. PubMed ID: 22970743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.